Skip to content

Clinical trials

Prostatic Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: New Zealand Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20041
20051
20092
20101
20111
20121
20134
20142
20161
20171
20192
20203
20212
20222
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting10
Recruiting5
Terminated2
Approved for marketing1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
University of Sydney3
Abbott2
Astellas Pharma Global Development, Inc.2
Janssen Research & Development, LLC2
Pfizer2
Trans Tasman Radiation Oncology Group2
Active Biotech AB1
Amgen1
Aragon Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms34
Neoplasms2
Bone Diseases, Metabolic1
Breast Neoplasms1
Cataract1
Endometrial Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1
Lower Urinary Tract Symptoms1
Osteoporosis1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.